Prognostic significance of the Gustave Roussy immune (GRIm) score in cancer patients: a meta-analysis.

ABSTRACT:

Background

The prognostic value of the Gustave Roussy immune (GRIm) score in cancer patients has been widely reported but remains inconsistent. The aim of this study is to systematically investigate the relationship between the GRIm score and survival outcomes in cancer patients.

Methods

Relevant literature was identified using electronic databases including Web of Science, PubMed, and Embase from the inception to March 2023. The primary endpoints were long-term oncological outcomes. Subgroup analysis and sensitivity analysis were conducted during the meta-analysis.

Results

Fifteen studies (20 cohorts) including 4997 cancer patients were enrolled. The combined results revealed that patients in the high GRIm group had a deteriorated overall survival (HR = 2.07 95%CI: 1

SUBMITTER: Sun KX 

PROVIDER: S-EPMC10586078 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature